Bicycle Therapeutics (BCYC) EBT Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -678,474.00 |
| Dec 31, 2025 | 44,867.00 |
| Sep 30, 2025 | 220,983.00 |
| Jun 30, 2025 | -209,191.00 |
| Mar 31, 2025 | -403,607.00 |
| Dec 31, 2024 | 544,351.00 |
| Sep 30, 2024 | -160,321.00 |
| Jun 30, 2024 | -16,529.00 |
| Mar 31, 2024 | 72,700.00 |
| Dec 31, 2023 | -9,591.00 |
| Sep 30, 2023 | -51,153.00 |
| Jun 30, 2023 | 43,215.00 |
| Mar 31, 2023 | -42,440.00 |
| Dec 31, 2022 | 55,420.00 |
| Sep 30, 2022 | -61,559.00 |
| Jun 30, 2022 | 40,025.00 |
| Mar 31, 2022 | 44,911.00 |
| Dec 31, 2021 | -82,574.00 |
| Sep 30, 2021 | 66,417.00 |
| Jun 30, 2021 | -9,817.00 |
| Mar 31, 2021 | -45,986.00 |
| Dec 31, 2020 | -17,849.00 |
| Sep 30, 2020 | 50,136.00 |
| Jun 30, 2020 | 23,515.00 |
| Mar 31, 2020 | -92,644.00 |
| Dec 31, 2019 | 151,216.00 |
| Sep 30, 2019 | -93,579.00 |
| Jun 30, 2019 | -56,181.00 |
| Mar 31, 2019 | 52,768.00 |
| Dec 31, 2018 | -15,052.00 |
| Sep 30, 2018 | -17,800.00 |
| Jun 30, 2018 | -19,541.00 |